Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

Vaccines, Blood & Biologics

Resubmission Letter - Wilate, June 24, 2009

Our STN:  BL 125251/0

 

Octapharma Pharmazeutika
Attention:  Mr. Stanley Ammons
Octapharma USA
121 River Street, 12th floor
Hoboken, NJ 07030

Dear Mr. Ammons:

We received your June 3, 2009, resubmission to your biologics license application for Coagulation Factor VIII/von Willebrand Factor Complex (Human) on June 4, 2009.

The resubmission contains your response to our January 8, 2008 complete response letter. 

We consider this a complete, class 2 response to our action letter.  Therefore, the user fee goal date is December 4, 2009.

If you have any questions, please contact the Regulatory Project Manager, Pauline Cottrell, at 827-6162.

Sincerely yours,

 

Jeffrey M. Anderson, M.S., RAC
Chief
Regulatory Project Management Branch
Division of Blood Applications
Office of Blood Research and Review
Center for Biologics
  Evaluation and Research

Page Last Updated: 03/31/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.